ANAPLASTIC LARGE CELL LYMPHOMA
Tracking # 20-814543
$99999.00
There are no ratings for this course
Learn more Educator STATPEARLS PUBLISHING, LLC
CE Broker Reporting Reported automatically
Method Computer-Based Training
Course overview
ANAPLASTIC LYMPHOMA KINASE POSITIVE (ALK+) ANAPLASTIC LARGE CELL LYMPHOMA (ALCL), IS A T-CELL LYMPHOMA CHARACTERIZED BY LARGE, PLEOMORPHIC LYMPHOID CELLS WITH ABUNDANT CYTOPLASM AND HORSESHOE-SHAPED NUCLEI, POSITIVE FOR CD30. ALK+ ALCL HAS ASSOCIATED RECURRENT T(2;5) FUSION TRANSLOCATION INVOLVING THE ALK GENE AND NUCLEOPHOSMIN (NPM1) GENE. THIS CME ACTIVITY OUTLINES THE EVALUATION AND MANAGEMENT OF ALK+ ALCL, WHILE HIGHLIGHTING THE ROLE OF THE INTERDISCIPLINARY HEALTHCARE TEAM IN THE MANAGEMENT OF THIS CONDITION.
Subject areas
This course counts toward the state boards and subject areas below.
Bahamas Medical Council
Specialty Medical Practitioner
1h
General Medicine
Louisiana State Board of Medical Examiners - Physicians & Surgeons
Physician & Surgeon
1h
Category I CME
Mississippi State Board of Medical Licensure
Medical Doctor
1h
AMA Category I
Physician Assistant
1h
AMA Category I
State Medical Board of Ohio
Doctor of Medicine
1h
AMA Category I